7VA1

Crystal structure of human 3-phosphoglycerate dehydrogenase in complex with GDD-04-35

External Resource: Annotation

Domain Annotation: ECOD Classification
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A [auth B]	PF02826	e7va1B1	A: a/b three-layered sandwiches	X: Rossmann-like	H: Rossmann-related	T: NAD(P)-binding Rossmann-fold domains	F: PF02826	ECOD (1.6)
B [auth A]	PF02826	e7va1A1	A: a/b three-layered sandwiches	X: Rossmann-like	H: Rossmann-related	T: NAD(P)-binding Rossmann-fold domains	F: PF02826	ECOD (1.6)
C	PF02826	e7va1C1	A: a/b three-layered sandwiches	X: Rossmann-like	H: Rossmann-related	T: NAD(P)-binding Rossmann-fold domains	F: PF02826	ECOD (1.6)
D	PF02826	e7va1D1	A: a/b three-layered sandwiches	X: Rossmann-like	H: Rossmann-related	T: NAD(P)-binding Rossmann-fold domains	F: PF02826	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A [auth B], B [auth A], C, D	PF02826	D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain (2-Hacid_dh_C)	D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain	This domain is inserted into the catalytic domain, the large dehydrogenase and D-lactate dehydrogenase families in SCOP. N-terminal portion of which is represented by family Pfam:PF00389.	Domain
A [auth B], B [auth A], C, D	PF00389	D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (2-Hacid_dh)	D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain	This family represents the largest portion of the catalytic domain of 2-hydroxyacid dehydrogenases as the NAD binding domain is inserted within the structural domain.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A [auth B], B [auth A], C, D	D-3-phosphoglycerate dehydrogenase	oxidoreductase activity oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor oxidoreductase activity, acting on CH-OH group of donors phosphoglycerate dehydrogenase activity catalytic activity electron transfer activity malate dehydrogenase activity L-malate dehydrogenase activity NAD binding binding nucleoside phosphate binding purine nucleotide binding organic cyclic compound binding adenyl nucleotide binding oxidoreductase activity oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor oxidoreductase activity, acting on CH-OH group of donors phosphoglycerate dehydrogenase activity catalytic activity electron transfer activity malate dehydrogenase activity L-malate dehydrogenase activity NAD binding binding nucleoside phosphate binding purine nucleotide binding organic cyclic compound binding adenyl nucleotide binding nucleotide binding heterocyclic compound binding small molecule binding	developmental process multicellular organism development multicellular organismal process head development central nervous system development anatomical structure development animal organ development brain development nervous system development system development spinal cord development cellular developmental process cell development glial cell development developmental process multicellular organism development multicellular organismal process head development central nervous system development anatomical structure development animal organ development brain development nervous system development system development spinal cord development cellular developmental process cell development glial cell development neurogenesis gliogenesis glial cell differentiation cell differentiation cellular process cell cycle G1 to G0 transition cell cycle process regulation of biosynthetic process regulation of biological process regulation of cellular process cellular biosynthetic process cellular metabolic process biological regulation regulation of cellular metabolic process regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process regulation of cellular biosynthetic process regulation of gene expression organic substance metabolic process biosynthetic process organic substance biosynthetic process regulation of macromolecule biosynthetic process metabolic process macromolecule metabolic process regulation of metabolic process serine family amino acid metabolic process oxoacid metabolic process organonitrogen compound biosynthetic process amino acid metabolic process organic acid metabolic process organic acid biosynthetic process alpha-amino acid metabolic process carboxylic acid biosynthetic process small molecule metabolic process organonitrogen compound metabolic process small molecule biosynthetic process carboxylic acid metabolic process primary metabolic process L-amino acid biosynthetic process L-serine metabolic process L-serine biosynthetic process L-amino acid metabolic process proteinogenic amino acid metabolic process amino acid biosynthetic process proteinogenic amino acid biosynthetic process serine family amino acid biosynthetic process alpha-amino acid biosynthetic process glycine metabolic process aspartate family amino acid metabolic process threonine metabolic process taurine metabolic process sulfur compound metabolic process alkanesulfonate metabolic process epithelium development neural tube development tube development chordate embryonic development embryo development tissue development embryo development ending in birth or egg hatching glutamine metabolic process glutamine family amino acid metabolic process gamma-aminobutyric acid metabolic process non-proteinogenic amino acid metabolic process monocarboxylic acid metabolic process plasma membrane bounded cell projection organization cell projection organization neuron projection development cellular component organization generation of neurons neuron differentiation neuron development cellular component organization or biogenesis	extracellular exosome membrane-bounded organelle extracellular vesicle extracellular organelle extracellular region organelle extracellular space cellular anatomical entity vesicle extracellular membrane-bounded organelle intracellular anatomical structure cytoplasm cytosol

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A [auth B], B [auth A], C, D	IPR029009	Allosteric substrate binding domain superfamily	Homologous Superfamily
A [auth B], B [auth A], C, D	IPR006139	D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain	Domain
A [auth B], B [auth A], C, D	IPR029752	D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site 1	Conserved Site
A [auth B], B [auth A], C, D	IPR036291	NAD(P)-binding domain superfamily	Homologous Superfamily
A [auth B], B [auth A], C, D	IPR006236	D-3-phosphoglycerate dehydrogenase	Family
A [auth B], B [auth A], C, D	IPR029753	D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site	Conserved Site
A [auth B], B [auth A], C, D	IPR045626	D-3-phosphoglycerate dehydrogenase, ASB domain	Domain
A [auth B], B [auth A], C, D	IPR006140	D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A [auth B], B [auth A], C, D	Pharos: O43175	PHGDH deficiency melanoma Neu-Laxova syndrome 1 non-small cell lung carcinoma Neu-Laxova syndrome prostate cancer liver cancer breast carcinoma medulloblastoma osteosarcoma pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia 3-phosphoglycerate dehydrogenase deficiency retinal disease Cell Transformation, Neoplastic cutaneous melanoma PHGDH deficiency melanoma Neu-Laxova syndrome 1 non-small cell lung carcinoma Neu-Laxova syndrome prostate cancer liver cancer breast carcinoma medulloblastoma osteosarcoma pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia 3-phosphoglycerate dehydrogenase deficiency retinal disease Cell Transformation, Neoplastic cutaneous melanoma intellectual disability malignant mesothelioma pancreatic ductal adenocarcinoma breast cancer subependymal giant cell astrocytoma interstitial cystitis liver neoplasm pancreatic intraductal papillary-mucinous carcinoma polycystic ovary syndrome psoriasis cutaneous lupus erythematosus inborn errors of metabolism leukodystrophy malignant ependymoma malignant pancreatic neoplasm

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.